검색어 : 통합검색[Cancer drug discovery and development]
총 10,586건 중 1,000건 출력
, 99/100 페이지
-
981
- Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3)
- Abdel-Rahman, Somaya A.; Rehman, Ashfaq Ur; Gabr, Moustafa T.; Department of Radiology, Molecular Imaging Innovations Institute (MI3) , Weill Cornell Medicine , New York , New York 10065 , United States; Department of Molecular Biology and Biochemistry , University of California, Irvine , Irvine , California 92697 , United States; (ACS medicinal chemistry letters, v.14, 2023, pp.629-635)
-
982
- Developmental Therapeutics Program at the NCI: molecular target and drug discovery process
- Monga, M; Sausville, EA; ; (Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, v.16, 2002, pp.520-526)
-
983
- Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
- Zhao, Zheng; Bourne, Philip E.; ; (Pharmaceuticals, v.15, 2022, pp.1322)
-
984
- Microfluidic co-cultures with hydrogel-based ligand trap to study paracrine signals giving rise to cancer drug resistance
- Patel, Dipali; Gao, Yandong; Son, Kyungjin; Siltanen, Christian; Neve, Richard M.; Ferrara, Katherine; Revzin, Alexander; Department of Biomedical Engineering; Department of Biomedical Engineering; Department of Biomedical Engineering; Department of Biomedical Engineering; Department of Discovery Oncology; Department of Biomedical Engineering; Department of Biomedical Engineering; (Lab on a chip, v.15, 2015, pp.4614-4624)
-
985
- Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase
- Anjum, Farah; Mohammad, Taj; Almalki, Abdulraheem Ali; Akhtar, Omar; Abdullaev, Bekhzod; Hassan, Md. Imtaiyaz; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.; Department of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.; Scientific Department, Akfa University, Tashkent, Uzbekistan.; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.; (Omics : a journal of integrative biology, v.25, 2021, pp.580-590)
-
986
- Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors
- Dong, Guangping; Yasgar, Adam; Peterson, Darrell L.; Zakharov, Alexey; Talley, Daniel; Cheng, Ken Chih-Chien; Jadhav, Ajit; Simeonov, Anton; Huang, Rong; Department of Medicinal Chemistry and Molecular Pharmacology, Center for Cancer Research, Institute for Drug Discovery , Purdue University , West Lafayette , Indiana 47907 , United States; National Center for Advancing Translational Sciences , National Institutes of Health , Rockville , Maryland 20892 , United States; Department of Biochemistry, Institute for Structural Biology, Drug Discovery and Development , Virginia Commonwealth University , Richmond , Virginia 23219 , United States; National Center for Advancing Translational Sciences , National Institutes of Health , Rockville , Maryland 20892 , United States; National Center for Advancing Translational Sciences , National Institutes of Health , Rockville , Maryland 20892 , United States; National Center for Advancing Translational Sciences , National Instit; (ACS combinatorial science, v.22, 2020, pp.422-432)
-
987
- Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
-
Ramzy, George M.;
Koessler, Thibaud;
Ducrey, Eloise;
McKee, Thomas;
Ris, Fré
dé
ric;
Buchs, Nicolas;
Rubbia-Brandt, Laura;
Dietrich, Pierre-Yves;
Nowak-Sliwinska, Patrycja;
Molecular Pharmacology Group, School of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva, Switzerland;
George.Ramzy@unige.ch (G.M.R.);Eloise.Ducrey@unige.ch (E.D.); Department of Oncology, Geneva University Hospitals, 1211 Geneva, Switzerland;Thibaud.Kossler@hcuge.ch (T.K.);Pierre-Yves.Dietrich@unige.ch (P.-Y.D.); Molecular Pharmacology Group, School of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva, Switzerland;George.Ramzy@unige.ch (G.M.R.);Eloise.Ducrey@unige.ch (E.D.); Division of Clinical Pathology, Diagnostic Department, University Hospitals of Geneva (HUG), 1211 Geneva, Switzerland;Thomas.A.McKee@hcuge.ch (T.M.);Laura.Rubbia-Brandt@unige.ch (L.R.-B.); Translational Department of Digestive and Transpla; (Cancers, v.12, 2020, pp.1423)
-
988
- Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
- Amin, Shahil; Bathe, Oliver F.; Cumming School of Medicine, Faculty of Graduate Studies, University of Calgary, Calgary, Canada; Department of Surgery, University of Calgary, Calgary, Canada; (BMC cancer, v.16, 2016, pp.850)
-
989
- Abstract 4556: Matrix properties regulate 3D tumor spheroid growth and cancer drug response
- Libby, Jaxson R.; Li, Linqing; Walker, Sarah R.; 1University of New Hampshire, Durham, NH.; 1University of New Hampshire, Durham, NH.; 1University of New Hampshire, Durham, NH.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.4556-4556)
-
990
- Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
- Norton, L; ; (Seminars in oncology, v.26, 1999, pp.1-4)
QUICK MENU
